Faculty
Kiran Vij.jpg

Kiran R. Vij, MD

Assistant Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia
Department of Pathology & Immunology

Clinical Interests

  • Hematopathology

Contact

  • 314-286-2354 (tel)
  • 314-362-7086 (fax)
  • 11th Floor Mid-Campus Center (office)
  • Division of Oncology
    Campus Box 8007
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110

Bibliography

  • HTLV-1 Viral Oncogene HBZ Induces Osteolytic Bone Disease in Transgenic Mice
    Esser AK, Rauch DA, Xiang J, Harding JC, Kohart NA, Ross MH, Su X, Wu K, Huey D, Xu Y, Vij K, Green PL, Rosol TJ, Niewiesk S, Ratner L, Weilbaecher KN
    Oncotarget 2017 Aug 27;8(41):69250-69263
  • A Phase II Trial of Neoadjuvant MK2206, an AKT Inhibitor, With Anastrozole in Clinical Stage 2 or 3 PIK3CA Mutant ER Positive and HER2 Negative Breast Cancer
    Ma CX, Suman V, Goetz MP, Northfelt DW, Burkard ME, Ademuyiwa F, Naughton MJ, Margenthaler J, Aft R, Gray RJ, Tevaarwerk AJ, Wilke LG, Haddad TC, Moynihan T, Loprenzi C, Hieken T, Barnell EK, Skidmore ZL, Feng YY, Krysiak K, Hoog J, Guo Z, Nehring L, Wisinski KB, Mardis ER, Hagemann IS, Vij K, Sanati S, Al-Kateb H, Griffith OL, Griffith M, Doyle A, Erlichman C, Ellis MJ
    Clin Cancer Res 2017 Sep 5; [Epub ahead of print]
  • Allogeneic Hematopoietic Cell Transplantation in Morphologic Leukemia-Free Aplastic State
    Rashidi A, Ali AM, Vij KR, Shanley R, Romee R, Cooley SA, Westervelt P, DiPersio JF, Miller JS, Weisdorf DJ, Ustun C
    Am J Hematol 2017 Sep;92(9):E549-E552
  • NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
    Ma CX, Gao F, Luo J, Northfelt DW, Goetz M, Forero A, Hoog J, Naughton M, Ademuyiwa F, Suresh R, Anderson KS, Margenthaler J, Aft R, Hobday T, Moynihan T, Gillanders W, Cyr A, Eberlein TJ, Hieken T, Krontiras H, Guo Z, Lee MV, Spies NC, Skidmore ZL, Griffith OL, Griffith M, Thomas S, Bumb C, Vij K, Bartlett CH, Koehler M, Al-Kateb H, Sanati S, Ellis MJ
    Clin Cancer Res 2017 Aug 1;23(15):4055-4065
  • Azacitidine Mitigates Graft-Versus-Host Disease Via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells in Vivo
    Cooper ML, Choi J, Karpova D, Vij K, Ritchey J, Schroeder MA, DiPersio JF
    J Immunol 2017 May 1;198(9):3746-3754
  • Tissue Polymerase Chain Reaction for the Diagnosis of Cytomegalovirus Disease After Allogeneic Hematopoietic Cell Transplantation
    Rashidi A, Vij KR, Buller RS, Wylie KM, Storch GA, DiPersio JF
    Am J Hematol 2017 Feb;92(2):E19-E20
  • Targeted Sequencing Informs the Evaluation of Normal Karyotype Cytopenic Patients for Low-Grade Myelodysplastic Syndrome
    Duncavage EJ, O'Brien J, Vij K, Miller CA, Chang GS, Shao J, Jacoby MA, Heath S, Janke MR, Elliott K, Fulton RS, Fronick C, O'Laughlin M, Westervelt P, Ley TJ, Wilson RK, Walter MJ
    Leukemia 2016 Dec;30(12):2422-2426
  • Aberrant Expression of Alpha-Fetoprotein in Intrahepatic Cholangiocarcinoma: An Exceptional Occurrence
    Vij K, Wang HL
    Int J Surg Pathol 2008 Apr;16(2):194-8
  • Mice Expressing a Dominant-Negative Ret Mutation Phenocopy Human Hirschsprung Disease and Delineate a Direct Role of Ret in Spermatogenesis
    Jain S, Naughton CK, Yang M, Strickland A, Vij K, Encinas M, Golden J, Gupta A, Heuckeroth R, Johnson EM Jr, Milbrandt J
    Development 2004 Nov;131(21):5503-13
  • Causes of Abnormal Uterine Bleeding
    Vij K
    Doctoral Thesis 1999